Skip to content
April 2, 2025
Latest
“legacytech” Legacy Compass secures £60,000 for end-of-life planning platform
How SportAI is changing the game for coaches, players, federations, and broadcasters
Restrata partners with MAX Security to offer stronger risk management
Biotech Aqemia secures €7M grant for drug discovery using deep physics
WeeFin Raises €25M for ESG data management platform
EU Information Service
Good news from around Europe
Home
Startups
EU Funding
About
Promote your project
Home
Startups
EU Funding
About
Promote your project
Search for:
Home
Tech
Research Headlines – BLUEPRINT for research success in blood disease therapy
Research Headlines – BLUEPRINT for research success in blood disease therapy
On
August 24, 2017
By
admin
The EU-funded BLUEPRINT project has generated extensive epigenome data on healthy and diseased blood cells, developed new analysis methods and uncovered new information on how the innate immune system works.
Powered by
WPeMatico
Share this:
Click to share on Facebook (Opens in new window)
Click to share on Twitter (Opens in new window)
Click to share on LinkedIn (Opens in new window)
Click to email a link to a friend (Opens in new window)
Click to print (Opens in new window)
Related
Post navigation
PREVIOUS POST
Previous post:
Success Stories – More sustainable, healthier wine? We’ll drink to that!
NEXT POST
Next post:
Eight European Regios are working together for a #circular #economy in the #interreg project @CircEconomy. Together we find #opportunities.